期刊文献+

蟾毒灵诱导骨肉瘤U-20S和U-20S/MTX300细胞系的凋亡 被引量:10

Bufalin induces apoptosis in osteosarcoma U-2OS and U-2OS methotrexate 300-resistant cell lines in vitro
原文传递
导出
摘要 目的 研究蟾毒灵对人骨肉瘤细胞株的增殖抑制和诱导凋亡作用.方法 以不同浓度的蟾毒灵分别作用于骨肉瘤细胞U-2OS和甲氨蝶呤(MTX)耐药骨肉瘤细胞U-2OS/MTX300.采用四甲基偶氮唑蓝(MTT)法检测细胞增殖,Hoechst 33258荧光染色检测细胞凋亡,流式细胞仪检测细胞周期,DNA琼脂糖凝胶电泳检测DNA ladder凋亡条带,Western blot法检测凋亡相关蛋白p53、bax和bcl-2的表达.结果 蟾毒灵能明显抑制骨肉瘤细胞的增殖,其对U-2OS和U-2OS/MTX300细胞的IC50值分别为(8.49±2.1)ng/ml和(10.19±1.7)ng/ml(P>0.05).蟾毒灵处理U2OS和U-2OS/MTX300细胞48 h后,细胞均出现明显的染色质凝集,有典型的凋亡小体产生.同时,蟾毒灵能诱导骨肉瘤细胞凋亡,其作用机制是通过阻滞细胞周期于G2/M期、上调p53、bax表达和下调bcl-2的表达来实现.结论 蟾毒灵能显著抑制人骨肉瘤细胞U-2OS和U-2OS/MTX300的生长,并诱导细胞凋亡,其抗骨肉瘤作用不受MTX耐药的影响. Objective To study the growth inhibition and apoptosis induction effects of bufalin on human osteosarcoma cell lines in vitro. Methods U-2OS and U-2OS/methotrexate (MTX) 300-resistant cell lines were treated with bufalin. Cell viability was assessed by MTT assay. Cell-cycle status, apoptosisinducing effects, and the expression of apoptosis-related proteins were evaluated by flow cytometry,fluorescent staining, DNA fragmentation assay, and Western blotting. Results Bufalin inhibited cell growth in both U-2OS and U-2OS/MTX300 cells. The IC50 values of bufalin for U-2OS and U-2OS/MTX300 cells were (8.49 ±2.1 ) ng/ml and ( 10.19 ± 1.7) ng/ml, respectively. The induction of G2/M cell-cycle arrest was also seen in the bufalin-treated cells. The bufalin-indued apoptosis was confirmed by increased expression of rumor suppressor protein p53, bax and decreased expression of bcl-2. Conclusion Bufalin inhibites the growth of and induces apoptosis in both MTX-sensitive and MTX-resistant human osteosarcoma U-2OS cell lines. The apoptosis-inducing effect of bufalin is not influenced by the presence of high levels of DHFR.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2010年第10期734-738,共5页 Chinese Journal of Oncology
基金 基金项目:广东省自然科学基金(4009423)
关键词 蟾毒灵 骨肉瘤 细胞系 肿瘤 细胞凋亡 甲氨蝶呤 Bufalin Osteosarcoma Cell lines,tumor Apoptosis Methotrexate
  • 相关文献

参考文献16

  • 1Marina N,Gebhardt M,Teot L,et al.Biology and therapeutic advances for pediatric osteosarcoma.Oncologist,2004,9:422-441.
  • 2Delepine N,Alkallaf S,Cornille H,et al.Progress and stagnation in chemotherapy protocols for primary osteosarcoma.Ann Med Interne (Paris),2003,154:12-24.
  • 3Cragg GM,Newman DJ.Discovery and development of antineoplastic agents from natural sources.Cancer lnvest,1999,17:153-163.
  • 4Abelson PH.Medicine from plants.Science,1990,247:513.
  • 5Watabe M,Kawazoe N,Masuda Y,et al.Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells.Cancer Res,1997,57:3097-3100.
  • 6Kawazoe N,Watabe M,Masuda Y,et al.Tiaml is involved in the regulation of bufalin-induced apoptosis in human leukemia cells.Oncogene,1999,18:2413-2421.
  • 7Yeh JY,Huang WJ,Kan SF,et al.Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells.Prostate,2003,54:112-124.
  • 8陈小义,呼文亮,徐瑞成,陈莉,钱进.蟾蜍灵对肝癌细胞SMMC 7721的细胞毒作用及生长相关基因表达的影响[J].中国药理学与毒理学杂志,2001,15(4):293-296. 被引量:42
  • 9Serra M,Reverter-Branchat G,Maurici D,et al.Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteostrcoma cells.Ann Oncol,2004,15:151-160.
  • 10尹军强,沈靖南.蟾酥水提取物抗骨肉瘤作用的体外研究[J].中国骨肿瘤骨病,2004,3(5):303-305. 被引量:11

二级参考文献27

共引文献55

同被引文献167

引证文献10

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部